125 related articles for article (PubMed ID: 24900265)
1. Aryltriflates as a Neglected Moiety in Medicinal Chemistry: A Case Study from a Lead Optimization of CXCL8 Inhibitors.
Moriconi A; Bigogno C; Bianchini G; Caligiuri A; Resconi A; Dondio MG; D'Anniballe G; Allegretti M
ACS Med Chem Lett; 2011 Oct; 2(10):768-73. PubMed ID: 24900265
[TBL] [Abstract][Full Text] [Related]
2. 2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors.
Allegretti M; Bertini R; Cesta MC; Bizzarri C; Di Bitondo R; Di Cioccio V; Galliera E; Berdini V; Topai A; Zampella G; Russo V; Di Bello N; Nano G; Nicolini L; Locati M; Fantucci P; Florio S; Colotta F
J Med Chem; 2005 Jun; 48(13):4312-31. PubMed ID: 15974585
[TBL] [Abstract][Full Text] [Related]
3. Fine-Tuning of GPCR-Chemokine Interactions. Design and Identification of Chemokine Analogues as Receptor Agonists, Biased Agonists, and Antagonists.
Navarro J
Biochemistry; 2019 Mar; 58(10):1432-1439. PubMed ID: 30726064
[TBL] [Abstract][Full Text] [Related]
4. Design of noncompetitive interleukin-8 inhibitors acting on CXCR1 and CXCR2.
Moriconi A; Cesta MC; Cervellera MN; Aramini A; Coniglio S; Colagioia S; Beccari AR; Bizzarri C; Cavicchia MR; Locati M; Galliera E; Di Benedetto P; Vigilante P; Bertini R; Allegretti M
J Med Chem; 2007 Aug; 50(17):3984-4002. PubMed ID: 17665889
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil chemotaxis caused by chronic obstructive pulmonary disease alveolar macrophages: the role of CXCL8 and the receptors CXCR1/CXCR2.
Kaur M; Singh D
J Pharmacol Exp Ther; 2013 Oct; 347(1):173-80. PubMed ID: 23912333
[TBL] [Abstract][Full Text] [Related]
6. Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation.
Planagumà A; Domènech T; Pont M; Calama E; García-González V; López R; Aulí M; López M; Fonquerna S; Ramos I; de Alba J; Nueda A; Prats N; Segarra V; Miralpeix M; Lehner MD
Pulm Pharmacol Ther; 2015 Oct; 34():37-45. PubMed ID: 26271598
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen alpha (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2.
Catusse J; Liotard A; Loillier B; Pruneau D; Paquet JL
Biochem Pharmacol; 2003 Mar; 65(5):813-21. PubMed ID: 12628493
[TBL] [Abstract][Full Text] [Related]
8. Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer.
Nasser MW; Raghuwanshi SK; Grant DJ; Jala VR; Rajarathnam K; Richardson RM
J Immunol; 2009 Sep; 183(5):3425-32. PubMed ID: 19667085
[TBL] [Abstract][Full Text] [Related]
9. The chemokine receptors CXCR1 and CXCR2 couple to distinct G protein-coupled receptor kinases to mediate and regulate leukocyte functions.
Raghuwanshi SK; Su Y; Singh V; Haynes K; Richmond A; Richardson RM
J Immunol; 2012 Sep; 189(6):2824-32. PubMed ID: 22869904
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist.
Gonsiorek W; Fan X; Hesk D; Fossetta J; Qiu H; Jakway J; Billah M; Dwyer M; Chao J; Deno G; Taveras A; Lundell DJ; Hipkin RW
J Pharmacol Exp Ther; 2007 Aug; 322(2):477-85. PubMed ID: 17496166
[TBL] [Abstract][Full Text] [Related]
11. Probing the role of CXC motif in chemokine CXCL8 for high affinity binding and activation of CXCR1 and CXCR2 receptors.
Joseph PR; Sarmiento JM; Mishra AK; Das ST; Garofalo RP; Navarro J; Rajarathnam K
J Biol Chem; 2010 Sep; 285(38):29262-9. PubMed ID: 20630874
[TBL] [Abstract][Full Text] [Related]
12. Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6.
Catusse J; Struyf S; Wuyts A; Weyler M; Loos T; Gijsbers K; Gouwy M; Proost P; Van Damme J
Biochem Pharmacol; 2004 Nov; 68(10):1947-55. PubMed ID: 15476666
[TBL] [Abstract][Full Text] [Related]
13. Cbl and Akt regulate CXCL8-induced and CXCR1- and CXCR2-mediated chemotaxis.
Lane HC; Anand AR; Ganju RK
Int Immunol; 2006 Aug; 18(8):1315-25. PubMed ID: 16798838
[TBL] [Abstract][Full Text] [Related]
14. The collagen-breakdown product N-acetyl-Proline-Glycine-Proline (N-alpha-PGP) does not interact directly with human CXCR1 and CXCR2.
de Kruijf P; Lim HD; Overbeek SA; Zaman GJ; Kraneveld AD; Folkerts G; Leurs R; Smit MJ
Eur J Pharmacol; 2010 Sep; 643(1):29-33. PubMed ID: 20599927
[TBL] [Abstract][Full Text] [Related]
15. CXCL8-induced FAK phosphorylation via CXCR1 and CXCR2: cytoskeleton- and integrin-related mechanisms converge with FAK regulatory pathways in a receptor-specific manner.
Cohen-Hillel E; Yron I; Meshel T; Soria G; Attal H; Ben-Baruch A
Cytokine; 2006 Jan; 33(1):1-16. PubMed ID: 16406804
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2.
Wolf M; Delgado MB; Jones SA; Dewald B; Clark-Lewis I; Baggiolini M
Eur J Immunol; 1998 Jan; 28(1):164-70. PubMed ID: 9485196
[TBL] [Abstract][Full Text] [Related]
17. Characterization of human T cells that regulate neutrophilic skin inflammation.
Schaerli P; Britschgi M; Keller M; Steiner UC; Steinmann LS; Moser B; Pichler WJ
J Immunol; 2004 Aug; 173(3):2151-8. PubMed ID: 15265952
[TBL] [Abstract][Full Text] [Related]
18. Discrete steps in binding and signaling of interleukin-8 with its receptor.
Wu L; Ruffing N; Shi X; Newman W; Soler D; Mackay CR; Qin S
J Biol Chem; 1996 Dec; 271(49):31202-9. PubMed ID: 8940121
[TBL] [Abstract][Full Text] [Related]
19. Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma.
Eck M; Schmausser B; Scheller K; Brändlein S; Müller-Hermelink HK
Clin Exp Immunol; 2003 Dec; 134(3):508-15. PubMed ID: 14632759
[TBL] [Abstract][Full Text] [Related]
20. At-line coupling of LC-MS to bioaffinity and selectivity assessment for metabolic profiling of ligands towards chemokine receptors CXCR1 and CXCR2.
Mladic M; Scholten DJ; Niessen WM; Somsen GW; Smit MJ; Kool J
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1002():42-53. PubMed ID: 26301479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
